eversyn
Latest round
- Seed
Last raised
- Feb 2025
Total raised
- $1.7M
Investors
- 2
About eversyn
Founded in 2022 in Magdeburg, Germany, eversyn GmbH specializes in glycan engineering and protein glycosylation through its advanced technology. Eversyn has completed 1 deal to date, which underlines its growth trajectory.Eversyn specializes in the development and commercialization of activated sugars and enzymes, which serve as critical components for glycan engineering and protein glycosylation. Their core product offerings include affordable activated sugars, which are vital for creating human milk oligosaccharides (HMOs), specialty carbohydrates, and therapeutic proteins. These products are designed to overcome existing bottlenecks in research and development by making high-value glycans accessible to both academic researchers and industrial users. Eversyn's innovative technology allows for the precise manipulation of these molecules, thus unlocking new applications in the fields of nutrition and biopharmaceuticals.Eversyn operates on a B2B model, providing its products directly to research institutions and industrial partners focusing on glycoengineering applications. Transactions typically involve clients placing bulk orders for activated sugars and enzymes, with pricing structures in place that reflect the value and performance of these specialized products. For instance, activated sugars are priced starting at EUR 220 for up to 10 grams, while enzymes for in vitro glycoengineering begin at EUR 390 for up to 500 units. The company ensures a price guarantee on its offerings, reinforcing its commitment to affordability and accessibility in the market. The company is focused on launching new products, including expanded offerings of activated sugars and enzymes targeted for the biopharmaceutical sector. Eversyn plans to enter new markets beyond the European Economic Area (EEA) by the end of 2026, highlighting its ambition to broaden its global footprint.
Who invested in eversyn
2 investors across 1 round
See all investors in eversyn
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 17, 2025
Amount
$1.7M
Investors
Questions about eversyn
Who invested in eversyn?
eversyn has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has eversyn raised?
eversyn has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did eversyn last raise money?
eversyn's most recent round on record is a Seed, in Feb 2025.
What does eversyn do?
Founded in 2022 in Magdeburg, Germany, eversyn GmbH specializes in glycan engineering and protein glycosylation through its advanced technology.
Where is eversyn headquartered?
eversyn is headquartered in Magdeburg, Germany.
Which VCs invest in companies like eversyn?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at eversyn's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like eversyn? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.